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Imposing Strict Products Liability on
Medical Care Providers
Bell v. Poplar Bluff Physicians Group
I. INTRODUCTION
"[I]t is insane to snuff out with legal paper those
who would light the candle of a cure...,,2
Most jurisdictions preclude strict product liability claims against medical
care providers? These jurisdictions have held, generally, that health care
professionals do not sell medical products used pursuant to courses of medical
treatment as is required under the products liability doctrine generally defined
by Restatement (Second) of Torts § 402A and adopted, with modification, a
majority of states.4  However, the Missouri Court of Appeals, in Bell v.
Poplar Bluffs Physicians Group, held strict products liability does apply to
medical care providers. The purpose of this Note is to analyze the Bell
decision in light of both (i) the policies and purposes to be served by strict
products liability and (ii) the magnitude of contravening law in Missouri and
elsewhere regarding the application of this doctrine to the medical profession.
1. 879 S.W.2d 618 (Mo. Ct. App. 1994).
2. Peter W. Huber, Safety And The Second Best: The Hazards Of Public Risk
ManagementIn The Courts, 85 COLUM. L. REv. 277, 337 (1985) (arguing regulatory
schemes are better able to handle societal risks, such as medical innovations, than the
court system).
3. See generally Annotation, Liability of Hospital or Medical Practitioner Under
Strict Liability in Tort or Breach of Warranty For Harm Caused By Drug, Medical
Instrument, or Similar Device Used in Treating Patient, 54 A.L.R. 3D 258 (1974 &
Supp. 1995); See also Richard L. Cupp, Sharing Accountability For Breast Implants:
Strict Products Liability And Medical Professionals Engaged In Hybrid Sales/Service
Cosmetic Products Transactions, 21 FLA. ST. U. L. REv. 873, 873-81 (1994); David
Crump & Larry A. Maxwell, Should Health Service Providers Be Strictly Liable For
Product Related Injuries? A Legal And Economic Analysis, 36 SW. L. J. 831, 831-34
(1982).
4. See infra note 15 and accompanying text and notes 31 to 77 and accompanying
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II. FACTS AND HOLDING
In 1987, Joanna Bell purchased a "temporomandibular interpositional
implant '5 from Poplar Bluff Physicians Group, doing business as Doctors
Regional Medical Center ("the hospital"). 6  Claiming the implant was
defective, Ms. Bell sought damages against the hospital under both strict
product liability (count I) and negligence (count II) theories! With respect
to count I, the hospital contended that strict product liability did not apply to
surgical implants because the hospital was not a "seller" under Restatement
(Second) of Torts § 402A.8 Summary judgment was granted in favor of the
defendant hospital, and Ms. Bell appealed.9 The Missouri Court of Appeals,
Southern District, reversed the grant of summary judgment and remanded the
cause for further proceedings, holding (i) hospitals are not exempt from strict
liability for defective medical devices sold to and implanted in its patients
and (ii) the statute of limitations for medical malpractice claims does not apply
to strict liability causes of action."
III. LEGAL BACKGROUND
A. The Development of Products Liability Law
Products liability is a fairly recent development in tort law, originating
in the 1963 California Supreme Court decision, Greenman v. Yuba Power
Products, Inc. 2 Justice Traynor, writing the court's opinion, stated the
reason for imposing strict liability on a manufacturer as being to insure that
the costs of defective products be borne by those engaged in the
manufacturing of such products.'" Within one year, § 402A of Restatement
(Second) of Torts4 was adopted by the American Law Institute as its
5. A temporomandibular interpositional implant (TMJ) is a jaw implant used to
counter the effects of temporo-mandibular joint syndrome-a condition causing
arthritis as well as jaw and facial discomfort. See Gary Taylor, A Discovery by
DuPont: Hidden Costs of Winning, THE NATIONAL LAW JOURNAL, March 27, 1995,
vol. 17, B1-B2.




10. Id. at 621
11. Id
12. 377 P.2d 897 (Cal. 1963).
13. Id. at 901.
14. Section 402A. Special Liability of Seller of Product for Physical Harm to
[Vol. 60
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definition of products liability. 5 The Restatement doctrine, a strict liability
doctrine, 6 places liability on those engaged in the business of marketing and
selling products found to be defective. 17 Since the Greenman decision and
User or Consumer.
(1) One who sells any product in a defective condition
unreasonably dangerous to the user or consumer or to his property is subject
to liability for physical harm thereby caused to the ultimate consumer or to
his property, if
(a) the seller is engaged in the business of selling such a
product, and
(b) it is expected to and does reach the user or consumer
without substantial change in the condition in which it is sold.
(2) The rule stated in Subsection (1) applies although
(a) the seller has exercised all possible care in the
preparation and sale of his product, and
(b) the user or consumer has not bought the product from
or entered into any contractual relation with the seller.
RESTATEMENT (SECOND) OF TORTS § 402A (1977).
15. Peter N. Swisher, Products Liability Tort Reform: Why Virginia ShouldAdopt
the Henderson-Twerski Proposed Revision of Section 402A, Restatement (Second) of
Torts, 27 U. RICH. L. REV. 856, 879 (1993).
16. See generally FRANK J. VANDALL, STRICT LIABILITY, 18-25 (1989).
17. RESTATEMENT (SECOND) OF TORTS, § 402A, cmt c. The rule under the
Restatement was not meant to apply to the occasional seller of a product, but rather
to those who market products. Id. at cmt. f. See also Crump & Maxwell, supra note
3, at 852 (stating that medical professionals "advertise, merchandise, or make medical
products available to the public").
Of further interest in the area of medical device liability are comment k and
comment i-both concerning unavoidably unsafe products or unreasonably dangerous
products. These sections may be helpful in arguing to preclude strict liability claims
from all medical device cases.
Comment k excludes products that are unavoidably unsafe. The relevant example
given in the comment is drugs and vaccines. The comment states such products are
justified despite the inherent risks associated with their development and use.
RESTATEMENT (SECOND) OF TORTS, § 402A, cmt. k. See Cupp, supra note 3, at 909-
11 (discussing the possibility of applying this comment to medical implant device
cases).
Comment i provides that product liability will only apply to products which are
unreasonably dangerous to consumers. An example of a reasonably dangerous
product, according to the comment, is tobacco which is not unreasonably dangerous
just because users may suffer ill side-effects. Id. at cmt i. Presently, jurisdictions are
preventing strict liability causes of action through federal pre-emption in the area of
medical devices. Federal pre-emption and class exemptions for certain products are
beyond the scope of this Note. See, however, Victor E. Schwartz, Robert P. Charrow,
and Mark A. Behrens, Following the Supreme Court's Analysis in Cipollone, Courts
3
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the adoption of § 402A, most jurisdictions have accepted the concept of
product liability in some form. 8
Scholars have developed a number of policy justifications for introducing
products liability into the realm of tort law. 9 The reason most accepted by
legal scholars for imposing strict products liability is that of loss shifting, or
loss spreading, whereby a loss resulting from consumer injury caused by a
defective product is shifted onto the manufacturer and sellers of the product
who are better able to bear, and spread, the cost of injury.20 Other policy
reasons for imposing strict product liability include protection of the safety
and health of product consumers,2 fairness considerations (in that liability
should be placed on those best able to control and eradicate the defect,
namely, the manufacturer and sellers of the product),' and deterrence of
unsafe product manufacturing and marketing.' Risk assumption by
manufacturers and sellers for their market participation has been offered as an
overriding consideration for imposing strict liability, encompassing the reasons
set forth above.24
In Keener v. Dayton Electric Mfg. Co.,' the Missouri Supreme Court
embraced § 402A as the law of products liability in Missouri.26 In adopting
Are Finding Broad Preemption in Sophisticated Medical Device Tort Litigation, 17 J.
OF PROD. AND TOXIC LiAB. 31 (1995). See also Connelly v. Iolab Corp., 1995 WL
250794 (Mo. Ct. App. 1995) (Missouri case applying federal preemption).
18. See Swisher, supra note 15, at 860; Richard W. Bieman, Strict Products
Liability: An Overview of State Law, 10 J. PROD. LIAB. 111 (1987).
19. See Marshall S. Shapo, THE LAW OF PRODUCTS LIABILITY 7-22 to 7-30
(1990); VANDALL, supra note 16, at 21-25; W. PAGE KEETON ET AL., PROSSER AND
KEETON ON THE LAW OF TORTS, § 98 (5th ed. 1984); See also Hoven v. Kelble, 256
N.W.2d 379, 390-91 (Wis. 1977); John W. Wade, On the Nature of Strict Tort
Liability For Products, 44 Miss. L. J. 825, 826 (1973); William L. Prosser, Assault
on the Citadel, 69 YALE L. J. 1099, 1114-1124 (1960); Greenman v. Yuba Power
Products, Inc., 377 P.2d 897, 901 (Cal. 1963)
20. VANDALL, supra note 16, at 20-21; See also Swisher, supra note 15, at 861;
William A. Worthington and David H. Timmins, Empirical Effects of Restatement
(Second) and Other Versions of Modern Product Liability Doctrine, 15 J. PROD. AND
ToXIc LiAB. 315 (1993).
21. VANDALL, supra note 16, at 21.
22. VANDALL, supra note 16, at 21-22.
23. Swisher, supra note 15, at 861. See also Crump & Maxwell, supra note 3,
at 854-55 (discussing the deterrence rationale in the context of the medical profession).
24. See generally KEETON ET AL., supra note 19.
25. 445 S.W.2d 362 (Mo. 1969).
26. Id at 364.
[Vol. 60
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§ 402A, the Court accepted the loss-shifting rationale posited by Justice
Traynor in Greenman27 as its own.28
The Missouri General Assembly codified Missouri products liability law
in 1987.29 The statute is nearly identical to § 402A, the essence of which
holds a defendant liable for the sale or transfer of a defective product
unreasonably dangerous to the ultimate user.
B. Products Liability and the Medical Profession
Despite general acceptance of strict products liability, states have refused
to apply the doctrine to the medical profession.3' The Wisconsin Supreme
Court expounded reasons for this refusal in Hoven v. Kelble.32 In Hoven, the
Court observed that providing medical services is different than selling goods
due to the experimental nature of the medical profession and the necessity of
27. Greenman v. Yuba Power Products, Inc., 377 P.2d 897 (Cal. 1963).
28. Keener, 445 S.W.2d at 364. See supra notes 12-14 and accompanying text.
29. Products liability claim defined. As used in §§ 537.760-537.765, the term
"products liability claim" means a claim or portion of a claim in which the plaintiff
seeks relief in the form of damages on a theory that the defendant is strictly liable for
such damage because:
(1) The defendant, wherever situated in the chain of commerce,
transferred a product in the course of his business; and
(2) The product was used in a manner reasonably anticipated;
and
(3) Either or both of the following:
(a) The product was then in a defective condition unreasonably
dangerous when put to a reasonably anticipated use, and the plaintiff was
damaged as a direct result of such defective condition as existed when the
product was sold; or
(b) The product was then unreasonably dangerous when put to
a reasonably anticipated use without knowledge of its characteristics, and
the plaintiff was damaged as a direct result of the product being sold
without an adequate warning.
Mo. REv. STAT. § 537.760 (1994).
See State ex rel. American Medical International, Inc. v. Sweeney, 845
S.W.2d 648, 652 (Mo. Ct. App. 1992) (Maus, J., dissenting) (Judge Maus noted that
the Missouri products liability statute, § 537.760 was a codification and slight
modification of the Restatement approach.).
30. Mo. REV. STAT. § 537.760 (1994). The Missouri Statute substitutes
"transferred a product in the course of business" for § 402A's language imposing
liability on sellers who are "engaged in the business" of selling. See supra notes 14
and 29.
31. See supra note 3. See also infra notes 35-70 and accompanying text.
32. 256 N.W.2d 379, 379 (Wis. 1977).
1995]
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such services to society.3 Possible cost increases in the medical profession
were also addressed as a reason to preclude strict liability actions against
doctors and hospitals.34 The Hoven court held that, because of the unknown
costs and the "inability to assess the results"3 of imposing strict liability on
the medical profession, the issue could be better addressed by the state
legislature.3
6
In a view slightly distinguishable from that in Hoven, a Wisconsin federal
district court held, in Johnson v. Sears, Roebuck and Co.,37 that hospitals
could be held strictly liable for the services they provide. However, the court
held a hospital could be strictly liable only for administrative services, not
professional services.38 The court noted that applying strict liability to
professional services might make health care professionals reluctant to provide
treatment, especially when the treatment involves new fields of medicine.39
The tenor of most judicial decisions regarding medical products liability
has been similar to that in Hoven and Johnson" as most jurisdictions have
been consistent in precluding strict products liability from consideration as a
theory of recovery in the medical setting regardless of the nature of the
medical product used.41 The types of products that have been excluded from
33. 1d. at 391.
34. However, the court questioned the persuasiveness of such an argument. Id.
at n.17.
35. Id. at 392.
36. Id at 393.
37. 355 F. Supp. 1065, 1067 (E.D. Wis. 1973).
38. Id. at 1067. The difference between professional and administrative services
was not fully explained by the court as it asserted that the distinction between the two
is "often vague." Id. The court did express that any service performed by a doctor
in treating patients was professional and that hospital services that merely aided in the
doctor's ability to treat patients was administrative or mechanical. Id. at 1066-67.
39. Id According to the court such imposition of liability would work a "serious
social disservice." Id.
Legal commentators have expressed similar concerns about the effects of strict
products liability on medical innovation. Several authors suggest that industrial and
medical innovation may be severely hampered by rising liability costs. Worthington
and Timmins, supra note 20, at 318-23; Richard A Epstein, Legal Liability For
Medical Innovation, 8 CARDOZO L. REV. 1139, 1142 ("Where products are subject to
more stringent standards than medical services, there is a risk that treatment (services)
will be substituted for products (goods), even when the latter is more suited to the
task."); See generally Man C. Maloo and Benjamin A. Neil, Products Liability
Exposure: The Sacrifice of American Innovation, 13 J. PROD. LIAB. 361, 371-72
(1991).
40. See infra notes 41 to 84 and accompanying text.
41. See supra and infra notes 35-70-and accompanying text. But cf Thomas v.
[Vol. 60
6
Missouri Law Review, Vol. 60, Iss. 3 [1995], Art. 7
https://scholarship.law.missouri.edu/mlr/vol60/iss3/7
MEDICAL CARE PROVIDERS
products liability in the medical field can be categorized as follows: blood and
tissue products,42 medical tools and equipment used incidental to the
treatment of patients, and medical devices (prosthetic devices, implants, etc.)
which themselves are the treatment prescribed.43
Blood products were early subjects of strict liability scrutiny. In
Perlmutter v. Beth David Hospital,' actually a breach of implied warranty
case, the New York Court of Appeals concluded that blood transfusions were
not "sales" but rather services.45 The court stated that the relationship
between medical care providers and patients existed to provide the patient
services and not products.46 State legislatures have followed the Perlmutter
example in passing "blood shield statutes". These statutes generally provide
that blood transfusions are services that are exempt from strict liability
claims.47
St. Joseph Hosp., 618 S.W.2d 791, 796-97 (Tex. Civ. App. 1981) (strict products
liability action allowed where defective hospital robe caught fire and injured patient);
Cunningham v. MacNeal Memorial Hosp., 266 N.E.2d 897, 902 (II. 1970) (blood
supplied by hospital during blood transfusion is a sale for strict liability purposes).
42. See, e.g, Osbom v. Irwin Memorial Blood Bank, 7 Cal. Rptr. 2d 101, 120-22
(Cal. Ct. App. 1992) (standard of care is a professional standard of care in actions
against blood banks and hospitals regarding defective blood supply); Howell v.
Spokane & Inland Empire Blood Bank, 785 P.2d 815, 820-22 (Wash. 1990) (transfer
of blood a service rather than a sale therefore falling outside of product liability
actions); Perlmutter v. Beth David Hosp., 123 N.E.2d 792,794-96 (N.Y. 1954) (action
for breach of implied warranty did not apply to blood since blood transfusion is
provision of a service and not a sale).
43. These classifications have no legal significance. They are used merely to
provide ease in understanding the history of product liability claims in the medical
field. See Crump & Maxwell, supra note 3, at 836-37 (similar distinctions between
classes of medical products were made as blood products and other medical products
were categorized separately).
44. 123 N.E.2d 792 (N.Y. 1954).
45. Id. at 795. The court stated that, "[t]he supplying of blood by the hospital
was entirely subordinate to its paramount function of furnishing trained personnel and
specialized facilities in an endeavor to restore plaintiff's health." Id. About the patient
the court noted, "[H]e goes there not to buy medicines or pills, not to purchase
bandages or iodine or serum or blood, but to obtain a course of treatment in the hope
of being cured." Id. at 796.
46. Id. at 795.
47. The following is an example of a blood shield statute:
The procurement, processing, distribution or use of whole blood, plasma,
blood products, blood derivatives and other human tissues, including but not
limited to comeas, bones, hearts or other organs for the purpose of
injecting, transfusing, or transplanting any of them into the human body is
declared to be, for all purposes, the rendition of a service by every person,
1995]
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Upon general agreement by jurisdictions as to the impropriety of
imposing strict liability on providers of blood products, courts shifted their
focus to products used incidentally to medical treatment. These products, like
blood products, have been held to be exempt from products liability claims by
reason of the sales/service distinction asserted by the Perlmutter court.48
Forceps,49 dental needles,5" surgical drapes,"' electric grounding pads,52
and catheters53 all have been excluded from product liability considerations.
An important early case concerning this category of products is Magrine
v. Krasnica.54 In Magrine, a dentist's hypodermic needle broke in the mouth
of a patient and the patient sued under products liability. The court noted the
rapid development of this theory,15 generally, but stated the essence of the
relationship between dentist and patient was that of providing a professional
service or skill.56 The court explained the policy of risk spreading, a tenet
of the products liability doctrine, was not a good policy consideration in the
firm, or corporation participating therein and, whether or not any
remuneration is paid therefor, is declared not to be a sale of such whole
blood, plasma, blood products, blood derivatives or other tissues, bones or
organs for any purpose subsequent to enactment of this section. It is further
declared that any implied warranties of merchantability and fitness for a
particular purpose shall not be applicable as to a defect that cannot be
detected or removed by reasonable use of scientific procedures or
techniques. Nothing herein shall relieve any person, firm or corporation
from negligence.
Mo. REV. STAT. § 431.069 (1994).
48. Cupp, supra note 3, at 878-81.
49. See Silverhart v. Mount Zion Hospital, 98 Cal. Rptr. 187 (Cal. Ct. App. 1971)
(hospital held not strictly liable for defective forceps used since hospital's relationship
with patient is that of a service and therefore is not focused on any product); Podrat
v. Codman-Shurtleff, Inc. 558 A.2d 895 (Pa. Super. Ct. 1989) (use of defective forceps
was incidental to hospital's primary function of providing medical services to patient).
50. Magrine v. Krasnica, 227 A.2d 539 (N.J. Super. Ct. Law Div. 1967), affid,
Magrine v. Spector, 250 A.2d 129 (N.J. 1969).
51. Racer v. Utterman, 629 S.W.2d 387, 398-99 (Mo. Ct. App. 1981).
52. North Miami Gen. Hosp. v. Goldberg, 520 So. 2d 650, 651-52 (Fla. Dist. Ct.
App. 1988).
53. Easterly v. HSP of Texas, Inc., 772 S.W.2d 211, 213 (Tex. Ct. App. 1989).
54. 227 A.2d 539 (N.J. Super. Ct. Law Div. 1967), affd, Magrine v. Spector, 250
A.2d 129 (N.J. 1969).
55. Id at 540.
56. Id at 543. The court noted the dentist did not place the needle into the
stream of commerce or promote its purchase. Id. The court also placed importance on
the fact the dentist had no control over discovery of the defect. Id.
8
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context of medical care because it would only serve to increase medical and
dental costs which, the court concluded, were already too high. 7
More recently, in a defective surgical grounding pad case, the Florida
Court of Appeals held a defendant hospital was a consumer of the grounding
pad it used to help perform its service of providing medical care.58 The
court concluded hospitals were not engaged in the business of selling products
and that strict liability would not be allowed where the professional services
could not have been provided without the use of the product.59
Likewise, in a Texas medical equipment case, the determinative factor in
precluding a products liability claim against a hospital for transfer of a
defective epidural kit (catheter) was the fact the catheter was "intimately and
inseparably connected to the professional service . .., and was not an
ordinary good sold to the general public.6'
The final category of medical goods from which products liability has
been precluded are those products that are themselves the source of healing,
i.e. pacemakers,62 implants,63 drugs," and other such medical devices.65
The use of these products, similar to the use of products in the previous
category of cases, presents sales/service hybrid situations in which aspects of
both sales and services exist.' Drugs and implants, however, are slightly
57. Id. at 545.
58. North Miami, 520 So. 2d at 652.
59. Id. (quoting 2 AM. PROD. LIAB. 3D § 16:83 (1987)).
60. Easterly, 772 S.W.2d at 213.
61. Id
62. See Hector v. Cedars-Sinai Medical Center, 225 Cal. Rptr. 595 (Cal. Ct. App.
1986); Cutler v. General Electric Co., 4 U.C.C. Rep. Serv. (Callaghan) 300, 301 (N.Y.
Sup. Ct. 1967) (insertion of pacemaker not a sale, and does not create seller/purchaser
relationship); St. Mary Medical Center, Inc., 639 N.E.2d 312, 315 (Ind. Ct. App. 1994)
(insertion of defective pacemaker not a sale under the products liability statute, but
rather a service under the medial malpractice statute.).
63. See, e.g., Cafazzo v. Central Medical Health Services, Inc., 635 A.2d 151,
152-54 (Pa. Super. Ct. 1993) (hospital found not strictly liable for defective
temporomandibular joint implant); Hoff v. Zimmer, Inc., 746 F. Supp. 872, 874-76
(W.D. Wis. 1990) (hospital found not strictly liable for defective hip prosthesis).
64. Dove v. Ruff, 558 N.E.2d 836, 839 (Ind. Ct. App. 1990) (doctor not liable
for making and selling drug to patient); Carmichael v. Reitz, 95 Cal. Rptr. 381, 392-93
(Cal. Ct. App. 1971) (doctor prescribing defective drug is not strictly liable for the
defect).
65. Betro v. GAC Int'l, Inc., 551 N.Y.S.2d 72, 72 (N.Y. App. Div. 1990)
(prescription for night brace did not constitute a "sale" as to impose strict liability upon
the health care provider as it was incidental to medical treatment).
66. Cupp, supra note 3, at 876-79. The sales/service hybrid refers to transactions
having both sales and service characteristics. Id at 876. The classic case defining the
1995]
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distinguishable from the foregoing products as drugs and implants are actually
transferred to the patient through prescription or implantation. An analysis
often used in examining cases involving products prescribed to or implanted
in patients has been described as an "essence of the transaction" analysis.'
This analysis focuses on the predominant aspect of the transaction (whether
sale or service) in determining if strict liability should lie against a medical
care provider. 8 The next two cases exemplify this type of analysis.
In Dove v. Ruff,69 the Indiana Court of Appeals held that although a
injury-causing drug was sold to a patient the doctor who sold the drug was
not susceptible to strict liability claims because (i) the practice of medicine is
primarily a service," and (ii) goods provided incidentally to the delivery of
health services do not remove the health care provider's actions from
malpractice considerations.7' The court believed the doctor was not engaged
in the business of selling products as defined in § 402A of Restatement
(Second) of Torts.72
Similarly, in Hector v. Cedars-Sinai Medical Center,73 the California
Court of Appeals held a pacemaker sold by a hospital was not subject to strict
products liability because the essence of the relationship between hospital and
patient was that of providing services.74 The court further stated the
hospital's pricing scheme for pacemakers did not suggest the hospital was in
the business of selling pacemakers." The California court, like the
sales/service hybrid is Newmark v. Gimbel's Inc., in which the plaintiff sued a
hairstylist for scalp damage caused by a defective wave solution. Id. at 877 (citing
Newmark v. Gimbel's, Inc., 258 A.2d 697 (N.J. 1969)). The transaction was hybrid
because it combined the service of styling one's hair with the sale of the wave
solution. Id
67. Cupp, supra note 3, at 878.
68. Cupp, supra note 3, at 878.
69. 558 N.E.2d 836 (Ind. Ct. App. 1990).
70. Id at 838.
71. Id.
72. Id. See also Carmichael, 95 Cal. Rptr. at 393. In Carmichael, a doctor
merely prescribed defective medicine. The court examined the relationship between
patient and doctor and found that a doctor is not a retailer. The court quoted the
Perlmutter decision regarding the relationship between care provider and patient in
making its finding. Id.
73. 225 Cal. Rptr. 595 (Cal. Ct. App. 1986).
74. Id at 597. In Hector, the court cited extensively the decisions in Silverhart,
Magrine, and Carmichael. For the full citation and a discussion of these cases, see
supra notes 49, 50 and 64, respectively.
75. Hector, 225 Cal. Rptr. at 599-600.
[Vol. 60
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aforementioned Magrine court,76 observed that strict liability might result in
higher costs of health care. 7
C. Strict Liability for Medical Professionals in Missouri
Missouri Courts have addressed the issue of medical profession strict
liability on only a few occasions. In Hershley v. Brown,8 the Court of
Appeals, Western District, citing medical product liability decisions from other
jurisdictions, held strict liability would not lie against a physician if no
negligence or fault were shown. 9
In Racer v. Utterman," the Eastern District Court of Appeals held strict
liability would not lie against a hospital for an injury caused by a surgical
drape that caught fire while a patient was in surgery. The court concluded the
surgical drape was not "sold" as the term is used in § 402A because (i) the
hospital, rather than the patient, was the ultimate consumer of the product, and
(ii) the hospital was not in the business of selling the product." This second
determinative factor is reminiscent of the "essence of the transaction" analysis
previously described.82
In State ex rel. American Medical International, Inc. v. Sweeney, 3 a
defective temporal mandibular joint interpositional implant resulted in injury.
The majority decided the case on procedural grounds and did not discuss the
substantive products liability issue. In a dissenting opinion, however, Judge
Maus did discuss the product liability issue, declaring that the doctrine was
applicable to hospitals providing injury-causing products." Judge Maus
76. See supra notes 54-57 and accompanying text.
77. Hector, 225 Cal. Rptr. at 602-02.
78. 655 S.W.2d 671 (Mo. Ct. App. 1983).
79. The court, in reaching this conclusion, relied upon rationale used in Hoven
v. Kelble and Carmichaelv. Reitz-two early medical strict products liability cases. Id
at 675. The Hershley court referred to language in the Hoven decision explaining that
medical services are necessary and that any increase in imposition of liability could
unduly increase medical costs and hamper medical developments. Id. at 675 (citing
Hoven v. Kelble, 256 N.W.2d 379, 391 (Wis. 1977)).
In Carmichael, the court held that a physician is not strictly liable for injuries
suffered as a result of a drug prescribed by the doctor. Carmichael, 95 Cal. Rptr. at
392-93. The Hershley court cited to language in Carmichael asserting the necessity
of negligence for claims against physicians. Hershley, 655 S.W.2d at 675 (citing
Carmichael, 95 Cal. Rptr. at 381).
80. 629 S.W.2d 387 (Mo. Ct. App. 1981).
81. Id. at 398.
82. See supra notes 67-77 and accompanying text.
83. 845 S.W.2d 648 (Mo. Ct. App. 1992).
84. Id. at 650.
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explained that the implant at issue was a product sold to the plaintiff and,
therefore, should be subject to the rule stated in Restatement (Second) of Torts
§ 402A."
To date these have been the most significant medical strict liability cases
decided by Missouri state courts. 6 However, the Missouri General Assembly
has addressed the use of medical products in the course of medical treatment
defining such use as "health care services."87 Missouri statutes provide that
in any claim against a health service provider for injuries resulting from
defective medical products, the plaintiff must show negligence (i.e. that the
health care provider failed to use such care as a reasonable prudent and
careful health care provider would use under similar circumstances).88
IV. INSTANT DECISION
In Bell, the Court of Appeals began its analysis by adopting Judge Maus'
dissent in Sweeney 9 concerning the application of products liability to
85. Id. at 649.
86. A retail pharmacy has been held liable for selling defective crutches for being
an entity "engaged in the business of selling such products." Welkener v. Kirkwood
Drug Store Co., 734 S.W.2d 233 (Mo. Ct. App. 1987). In a blood transfusion case,
a federal district court relying on the Missouri blood shield statute, Mo. REV. STAT.
§ 431.069, held that products liability would not lie against the American Red Cross
for providing HIV tainted blood. Smith v. Paslode Corp., 799 F. Supp. 960, 972-73
(E.D. Mo. 1992), affd in part, rev'd in part, 7 F.3d 116 (8th Cir. 1993). The court
stated that such an imposition of liability inconsistent with the state's blood shield
statute might deter the necessary production and distribution of blood products. Id. at
973. See also Spuhl v. Shiley, Inc., 795 S.W.2d 573, 577-81 (Mo. Ct. App. 1990)
(The doctrine of strict liability was considered applicable to the manufacturer of a
defective heart valve).
Importantly, the Missouri Court of Appeals has refused to extend strict liability
to other professionals such as architects reasoning that such liability on was
inconsistent both with the rationale of risk spreading and with the consumer related
origins of strict products liability. Chubb Group of Insurance Co. v. C.F. Murphy &
Associates, Inc., 656 S.W.2d 766, 779-80 (Mo. Ct. App. 1983).
87. Mo. REV. STAT. § 538.205 (1994). See Judge Maus' dissent in Sweeney,
which describes this and other health care statutes in finding these sections applicable
to medical product defect claims. Sweeney, 845 S.W.2d 652-54 (Maus, J., dissenting).
88. Mo. REV. STAT. § 538.225 (1994). The Missouri Supreme Court has
observed that the medical tort statutes were enacted as an attempt to curb medical costs
attributable to unfounded malpractice claims and to ensure the "preservation of the
public health." Mahoney v. Doerhoff Surgical Services, Inc., 807 S.W.2d 503, 507
(Mo. 1991).
89. See supra notes 81-83 and accompanying text.
[Vol. 60
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medical implants. The Bell court stated that Judge Maus' analysis of medical
product sales was "well-reasoned and relevant" to the instant case.9"
Upon finding Hershley's91 negligence standard for medical providers
inapplicable to the Bell facts,' the court turned its attention to the role of the
hospital as a seller. The court stated products liability should arise regardless
of whether the product sold is a substantial part of the hospital's business.93
According to the court, the fact a sale is incidental to the purpose of a hospital
is irrelevant.94
The court then explained that a "sale" is not required under Missouri
product liability law, and that a "transfer" of the product is all that is
necessary for a party to be liable under the doctrine.95 The court stated that
placing the product "in the stream of commerce" through a variety of means
could lead to strict liability.96
Upon establishing a party could be liable under products liability for
merely transferring a defective product to another party, regardless of whether
the transfer or sale was incidental to the primary purpose of the defendant's
actions, the court turned to decisions from Missouri and elsewhere exempting
hospitals from strictly product liability claims. "
The court first distinguished the Missouri case Racer v. Utterman,98
stating that since the hospital was a user of the surgical drape at issue in that
case, and not a transferor of the drape, the case was not controlling."
The court then concluded, contrary to the holding in Hector v. Cedars-
Sinai Medical Center,' that an organization can both sell products and
provide services.' The Bell court next dismissed the assertion made by a
90. Bell, 879 S.W.2d at 619.
91. Hershley, 655 S.W.2d at 675.
92. The court intimated that the Hershley decision centered upon the conduct of
the physician, whereas, in Bell, the issue concerned the defective product and not the
conduct of the hospital. Bell, 879 S.W.2d at 619.
93. Id
94. Id Comparing the instant case to one in which the hospital sells a defective




98. See supra note 80 and accompanying text.
99. Bell, 879 S.W.2d at 620.
100. See supra notes 73-75 and accompanying text. In Hector, the court held
that, in the case of a defective pacemaker, the hospital was a provider of services and
not an entity engaged in the selling of products. Hector, 225 Cal. Rptr. at 601-02.
101. Bell, 879 S.W.2d at 620 (citing Murphy v. E.R. Squibb & Sons, Inc., 710
P.2d 247, 251 (Cal. 1985)).
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Pennsylvania superior court that a hospital could not be strictly liable for a
product defect since it was in no better position than the patient to detect and
control product defects. °2 The court believed this to be true of all retailers
selling defective products. 3
The court's final reference to a decision from another jurisdiction was
Greenberg v. Michael Reese Hospital,"M in which the Illinois Supreme
Court explained that the sales/service distinction formulated by other
jurisdictions was a distortion used to achieve desired results.' The Bell
court quoted the Greenberg court, which stated that "imposition of [strict]
liability enhances the public interest in human life and health."'" As
provided in the Bell decision, the Greenberg court did note that care should
be taken in imposing such liability on the conduct of groups whose purpose
it is to protect life and health so as to prevent an "ultimate diminution of
protection". 7
In finding the plaintiff in the instant case to be attacking the implant
rather than the conduct of the hospital, the Bell court concluded, "[T]he sales
aspect of the transaction may predominate over the service aspect and the
policy of strict liability in tort is served by allowing this action". 0 8 The
court found that neither the Missouri Supreme Court nor the General
Assembly intended to prevent such action."°  The court referred to the
Missouri products liability statute and found no exceptions for health care
providers."'
Upon finding the products liability statute applicable to the instant case,
the court considered whether the products liability claim could be barred by
the medical malpractice statute of limitations."' The court determined that
since malpractice requires negligence, or error, and products liability does not,
product liability claims, by definition, fall outside the malpractice statute of
limitations." 2
102. Id. (citing Cafazzo v. Central Medical Health Services, Inc., 635 A.2d 151,
154 (Pa. Super. Ct. 1993)).
103. Id. (implying that this proposition would be in contravention of the dictates
of products liability law).
104. 415 N.E.2d 390 (Ill. 1980)
105. Id at 393.




110. Id. at 620-21. See supra note 29.
111. Bell, 879 S.W.2d at 621-23.
112. Id. at 623.
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Examination of the Bell decision leads to three important inquiries-(i),
whether the court fairly interpreted the definitional restrictions generally
placed on products liability claims, using the Restatement and its comments
as a guide, (ii) whether the Bell decision contravenes the rationales upon
which the products liability doctrine rests, and (iii) whether the Missouri
General Assembly's declarations concerning medical care liability exempts the
medical profession from strict liability claims.
A. Definitional Considerations
The Bell court found, simply, that the temporo-mandibular implant was
a product within the meaning of the term under products liability law and that
the hospital had sold the good as defined by that law."'
In doing so, the court failed to fully address the significance of the
relationship between hospital and patient.' Under the Restatement, the fact
a product has been sold, alone, is not enough to create liability." 5
Restatement (Second) of Torts, explains that a party should be engaged in the
business of selling before products liability claims can arise."6 Furthermore,
the Restatement has placed emphasis on the seller as a marketer of the
defective product as a reason for establishing liability."7
The majority of courts, in evaluating defective implant claims based on
their jurisdictions' products liability laws, have applied the "essence of the
transaction" test"' to determine that physicians and hospitals are not
engaged in the business of selling medical products but rather are engaged in
the practice of treating illnesses-a service." 9 If in fact the fundamental
purpose of hospitals is providing service rather than selling products then, by
definition, hospital activities should fall outside product liability
considerations. 2 '
113. Id at 620.
114. REsTATEMENT (SECOND) OF TORTS, § 402A, cmt. f (1965).
115. See supra note 17 and accompanying text.
116. RESTATEMENT (SECOND) OF TORTS, § 402A, cmt. f(1965). However, under
the Missouri products liability statute, the seller need. only sell "in the course of his
business." See supra note 29.
117. See supra note 17 and accompanying text.
118. See supra notes 65-73 and accompanying text.
119. See supra notes 65-73 and accompanying text.
120. But cf comment f of Restatement (Second) of Torts § 402A does state that
a provider of services, such as a movie theater, would be liable for the popcorn it sells
even though this activity may be secondary to its service of providing entertainment.
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Problems arise, however, because of a slight textual difference existing
between § 402A of the Restatement and the Missouri products liability statute.
Under the Restatement, liability is imposed when a person is "engaged in the
business" of selling a defective product, whereas the Missouri statute imposes
liability when a party sells or transfers a defective product in the "course of
his business".' Such a distinction may justify imposing liability on
hospitals as the Missouri statute does not explicitly require a business to be
"engaged in the business of selling" a defective product. The Bell court did
not mention this textual difference, however, declining altogether to
accept the view that the fundamental purpose of a business should be a
determining factor in imposing strict liability.'
B. Policy Considerations
Besides possible inconsistency with § 402A, as modified by Missouri's
products liability statute, 24 the Bell decision appears inconsistent with the
policies underlying strict products liability.
The Bell court spent little time distinguishing Hershley v. Brown from the
instant case."z The Hershley court specifically stated that physicians are not
to be held to a strict liability standard of care. 26 Hospitals, statutorily, are
held to the same standard of care as physicians for medical services
provided. 27 By imposing strict liability on products transferred in the
course of medical treatment, the Bell court replaced, in certain circumstances,
the professional standard of care previously accepted by the courts of
Missouri, in Hershley, and by the legislature.' This general result may be
an especially important consideration in medical fields where medical
equipment or pharmaceutical products may be heavily relied upon. Such
liability may deter medical professionals from seeking innovations as solutions
RESTATEMENT (SECOND) OF TORTS, §402A, cmt. f (1965).
121. See supra notes 14, 29-30.
122. Bell, 879 S.W.2d at 619. The Bell court gave made little mention of the
business of hospitals, finding this determination unimportant. Id.
123. The court in Racer v. Utterman did use an essence of the transaction
analysis, placing importance on the fact the hospital was not engaged in the business
of selling the product at issue. Racer, 629 S.W.2d at 398.
124. See supra note 29 and accompanying text.
125. Bell, 879 S.W.2d at 619.
126. Hershley, 655 S.W.2d at 675.
127. Mo. REv. STAT. § 538.205 (1994).
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to medical ailments, instead forcing these professionals to rely on traditional
methods of care that may be less effective yet less susceptible to liability. 29
An additional policy consideration and its consequences should have been
more thoroughly scrutinized by the court. The Missouri Supreme Court
accepted the strict liability rationale of loss shifting 3 ' in Keener:" the
belief that of two parties-the consumer and producer-the burden of
assuming the loss caused by injury should be borne by a producer or seller
who can spread the loss more easily than an injured consumer.'3 2  In
assuming such loss, producers and sellers, in turn, can increase their prices to
offset the increased financial burden.' The cost of medical care may be
increased in a similar manner, as courts and commentators have explained.'
This may be especially detrimental to needy patients as increased prices may
not cause a measurable decline in the need for necessary treatments with few
alternatives. 3 ' Perhaps an even more detrimental effect of imposing strict
liability on hospitals and physicians than price increases is the possibility such
liability, with its attendant litigation cost increases, might deter physicians and
small medical facilities from providing care in less profitable rural or inner-
city markets, instead forcing medical professionals to leave these markets
altogether.
36
129. Johnson v. Sears, Roebuck and Co., 355 F. Supp. 1065, 1067 (E.D. Wis.
1973) (In the face of strict liability, professionals might be reluctant to provide
treatment); See also Cupp, supra note 3, at 880; text accompanying supra notes 32 and
34; supra note 38; and Arthur Leff, Medical Devices and Paramedic Personnel: A
Preliminary Context for Emerging Problems, 1967 WASH U. L. Q. 332, 355 (1967).
130. See supra note 25 and accompanying text.
131. See supra note 28 and accompanying text.
132. See supra note 25-28 and accompanying text.
133. KEETON ET AL., supra note 19, at § 98.
134. Magrine, 227 A.2d at 545 (risk spreading in the medical context would serve
to greatly increase medical costs that were already too high); Hoven, 256 N.W.2d at
391 and n.17 (recognizing that strict liability will increase medical cost, but
questioning the persuasiveness of that argument for denying strict liability); Hector,
225 Cal. Rptr. at 601-02 (agreeing that strict liability might result in higher costs of
health care). See also Cupp, supra note 3, at 890-91.
135. VANDALL, supra note 16, at 112 (asserting that medical care has an inelastic
demand, such that if prices go up, demand will not measurably decline). See also
Frank J. Vandall, Applying Strict Liability To Professionals: Economic and Legal
Analysis, 59 IND. L. J. 25, 38-39 (1984) (stating a large portion of medical expenses
are not covered by insurance). See also Cupp, supra note 3, at 880; Crump &
Maxwell, supra note 3, at 846.
136. Some authors assert that liability costs force market competitors to leave the
market, thus leaving fewer consumer choices. Worthington and Timmins, supra note
20, at 318-23. Maloo and Neil, supra note 39, at 371-72. Both of these articles refer
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The adoption of an "essence of the transaction" analysis to preclude strict
product liability claims in the medical field may be justified when considering
the foregoing purposes served by and results flowing from imposition of strict
liability. 3  However, unlike most courts,' the Bell court did not
consider the special burdens placed upon the medical profession when
imposing strict products liability with its loss-shifting rationale.
C. Legislative Intent
Besides failing to address general policy considerations associated with
products liability, the Bell court may have refused a specific legislative
mandate prohibiting the imposition of strict liability upon health care
providers. In language reminiscent of the "essence of the transaction"
approach described above, the statute providing for actions in tort against the
medical profession states the following:
Professional services shall include, but are not limited to, transfer to a
patient of goods or services incidental or pursuant to the practice of the
health care provider's profession or in furtherance of the purposes for which
an institutional health care provider is organized.'39
Hospitals are defined by statute as health care providers. 4  The
medical tort statutes further provide that if injury results from professional
services rendered, the injured party must present an affidavit stating the injury
was caused by a health care provider's negligence."' This language
to drug manufacturers' mass exodus from particularly risky ventures in the area of
vaccines. Cupp, supra note 3, at 880 (citing to Newmark v. Gimbel's Inc. 258 A.2d
697, 702-03); Crump & Maxwell, supra note 3, at 853 (noting the harmful effect of
litigation on rural hospital cost increases).
137. See generally Cupp, supra note 3; Crump & Maxwell, supra note 3.
138. See Hoven, 256 N.W.2d at 391 (the services of the medical profession are
necessary to society); Johnson, 355 F. Supp. at 1067 (recognizing that strict liability
might make the medical profession reluctant to provide treatment); Magrine, 227 A.2d
at 543 (because the dentist primarily provides a service, he had no control over
discovery of the defect); Hector, 225 Cal. Rptr. at 597 (the doctor-patient relationship
is based on the giving and receiving of services, not goods).
139. Mo. REV. STAT. § 538.205 (1994) (emphasis added).
140. Id.
141. Mo. REv. STAT. § 538.225 (1994). Furthermore, § 538.300 provides that
the product liability sections shall not apply to actions under the medical tort statutes
described above. However, this section is inapplicable to the Bell case as the injury
occurred prior to the effective date of the statute. Mo. REV. STAT. § 538.300 (1994)
(effective in 1988).
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suggests that if a product transferred pursuant to a course of medical treatment
causes injury, the injured party must show a medical care provider's
negligence in order to recover against that medical care provider. Such a
reading, which ultimately limits medical care provider liability to professional
negligence only, seems consistent with the Missouri Supreme Court's
observation that the affidavit process requiring a showing of negligence was
intended to curb medical costs associated with malpractice claims and to
ensure the "preservation of the public health."'42 The failure to consider this
statutory scheme in defective medical device cases, or, at least, the failure to
interpret the statute as limiting liability to negligence in such cases would
seem contrary to the Missouri Supreme Court's observation that the medical
tort statutes were enacted to control excessive medical costs resulting from
claims against medical care providers.'43
The Bell court, however, did not discuss the medical tort statutes,
declaring instead (i) that the legislature had not asserted any intention to
preclude product liability claims against medical care providers and (ii) that
products liability actions, being no fault actions, fall outside of the malpractice
statute of limitations.'" The medical tort statutes should have been
addressed by the Bell court as, contrary to the court's view, the Missouri
General Assembly has definitively spoken on whether to include medical
products within the traditional malpractice standard. 4 Despite the outcome
reached in Bell, the General Assembly has arguably exempted all future
medical device claims from products liability consideration. 46
In summary, the Bell court concluded that the implant at issue was a
defective product falling within products liability law.'47 In so doing, the
court should have given greater consideration to (i) the nature of the health
care industry as related to products liability policies and rationale,14 (ii) the
economic consequences of imposing such liability on the medical profession,
142. Mahoney v. Doerhoff Surgical Services, Inc., 807 S.W.2d 503, 507 (Mo.
1991).
143. Further examination of the medical tort statutes provide additional evidence
of the legislature's intent to limit medical care liability to professional negligence.
Section 538.300 of the medical tort statutes provides that strict product liability claims
are precluded in all actions falling under the medical tort statutes. Mo. REv. STAT.
§ 538.300 (1994).
144. Bell, 879 S.W.2d at 621.
145. Id.
146. Mo. REv. STAT. § 538.300, which precludes product liability claims in
medical tort actions was not effective at the time of Bell, but would seem to control
in future defective medical product claims.
147. Bell, 879 S.W.2d at 620.
148. See supra notes 42-76 and accompanying text.
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and (iii) the guidance provided by the General Assembly concerning medical
device exclusions from products liability law. Regardless of the propriety of
the court's holding, its decision would have been less susceptible to future
scrutiny had these issues been explored more fully.
VI. CONCLUSION
The medical field is a rapidly evolving and complex one, with legal and
ethical considerations weighing heavily in innovative treatment decisions. We
place the medical profession in a difficult position when holding it strictly
accountable for treatment based injuries while asking it to become more cost-
effective and accessible to those the medical system is designed to help.
Exacting strict products liability against the medical profession requires a more
exhaustive analysis of the purposes to be served by such a policy than that
given by the Bell court in its decision. Indeed such analysis, may have been
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